Document is current
Any future updates will be listed below
-
Authors
Baker, Dave J.
Aydin, Alp
Le-Viet, Thanh
Kay, Gemma L.
Rudder, Steven
de Oliveira Martins, Leonardo
Tedim, Ana P.
Kolyva, Anastasia
Diaz, Maria
Alikhan, Nabil-Fareed
Meadows, Lizzie
Bell, Andrew
Gutierrez, Ana Victoria
Trotter, Alexander J.
Thomson, Nicholas M.
Gilroy, Rachel
Griffith, Luke
Adriaenssens, Evelien M.
Stanley, Rachael
Charles, Ian G.
Elumogo, Ngozi
Wain, John
Prakash, Reenesh
Meader, Emma
Mather, Alison E.
Webber, Mark A.
Dervisevic, Samir
Page, Andrew J. https://orcid.org/0000-0001-6919-6062
O’Grady, Justin
-
Funding
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/R012504/1, BB/CCG1860/1, BB/R012490/1)
ISCIII (CD018/0123)
- License Information
-
More Information
Article History
Received: 7 July 2020
Accepted: 26 January 2021
First Online: 9 February 2021
Ethics approval and consent to participate
: The COVID-19 Genomics UK Consortium has been given approval by Public Health England’s Research Ethics and Governance Group (PHE R&D Ref: NR0195). Written informed consent was not required as only excess diagnostic samples were used and no patient identifiable information was collected or presented. The research conformed to the principles of the Helsinki Declaration.
: Not applicable
: LG received a partial support for his PhD from Roche. The use of Roche technology for diagnostics in NNUH is coincidental. The authors declare that they have no competing interests.
